Search database
LIST OPTIONS
Filter
50
Filtered Results: 50
Text search: pharmacovigilance policy handbook
Featured
Language
Document type
No document type
28
Guidelines
10
Manuals
6
Studies & Reports
3
Strategic & Response Plan
2
Training Material
1
Countries / Regions
Eastern Europe
4
Russia
3
India
3
Kenya
2
Global
2
Western and Central Europe
2
Ukraine
1
Ghana
1
Nigeria
1
Zimbabwe
1
Latin America and the Carribbean
1
Tanzania
1
South Africa
1
Uganda
1
Georgia
1
Zambia
1
Liberia
1
Authors & Publishers
World Health Organization WHO
13
World Health Organisation (WHO)
4
International Pharmaceutical Federation
2
WHO
2
Wiedenmayer, K. et al.
2
A. Montresor
1
A. Piubello
1
BMC Health Services Research
1
CCM Georgia
1
Central TB Divison, Ministry of Health and Social Welfare, Government of India
1
Christina Brandes-Barbier, Véronique Millot, Tomas Allen et al
1
et al.
1
Federal Ministry of Health, Nigeria
1
Government of India, Central Tuberculosis Division, Ministry of Health and Family Welfare
1
International Pharmaceutical Federation (FIP)
1
Kwonjune J. Seung, Michael L. Rich, Amy Elizabeth Barrera-Cancedda et al.
1
Medicines Control Authority of Zimbabwe (MCAZ) | Ministry of Health and Child Care
1
Ministry of Health & Family Welfare, India
1
Ministry of Health, Kenya
1
Ministry of Health, Republic of Uganda
1
MSH, USAID
1
Organisation Mondiale de la Santé OMS
1
Organización Mundial de la Salud (OMS), Federación Internacional Farmacéutica (FIP)
1
Organización Mundial de la Salud OMS
1
Pan American Health Organisation PAHO
1
Republic of Kenya, Ministry of Health
1
Republic of Libera, Ministry for Health and Social Welfare
1
Rochweg, B.
1
Systems for Improved Access to Pharmaceuticals and Services (SIAPS)
1
Tanzania Food & Drugs Authority (TFDA)
1
The International Union Against Tuberculosis and Lung Disease
1
USAID
1
USAID, TBCARE I, TBCARE II
1
Velisha Ann Perumal-Pillay & Fatima Suleman
1
World Health Organization
1
World Health Organization (WHO)
1
World Health Organization (WHO), International Pharmaceutical Federation (FIP)
1
World Health Organization Europe
1
World Health Organization WHO, Stop TB
1
World Health Organization, Europe
1
World Health Organization, Regional Office for South-East Asia
1
World Health Organization, Western Pacific
1
Zambia Medicines Regulatory Authority (ZAMRA)
1
Всемирная организация здравоохранения
1
Publication Years
Category
Drugs & Medical Equipment
8
TB
7
Policies & Guidelines HIV & TB
5
Guidelines
4
Malaria
4
NTDs & Others
3
Taeniasis/ Cysticercosis
2
Leprosy
2
Hepatitis
1
Helminthiasis
1
Pharmacy & Technology
1
Trachoma
1
Onchocerciasis
1
Schistosomiasis
1
Lymphaticfilariasis
1
Non-communicable Diseases NCD
1
Vaccine-preventable Diseases
1
Clinical Guidelines
1
Studies & Reports
1
General Guidelines
1
Communicable Diseases
1
Non-communicable Diseases
1
HIV & STI
1
Key Resources
1
Toolboxes
Drug resistant TB
8
Adults
3
Children
2
International
2
Pharmacy Practice
2
Rational use of Medicine
2
Clinical Guidelines
1
Childhood TB
1
Clinical Guidelines
1
Country specific
1
WPRO (Western Pacific Region)
1
Public Health
1
Georgia
1
Reports
1
Russia
1
Clinical Guidelines
1
Supporting tools
1
Health Personnel
1
General
1
Essential Medicines & Devices Lists
1
General Guidelines for Rational Use
1
Clinical Aspects & Diagnosis
1
Prevention & Strategies
1
Diagnosis
1
Neurological Disorders
1
Training
1
TB/HIV Coinfection
1
Clinical Guidelines
1
Western & Central Europe
1
Antiretroviral Treatment ART
1
TB
1
Eastern Europe & Central Asia
1
Meningitis & Encephalitis
1
SEAR (South-east Asia Region)
1
Treatment & Clinical Management
1
Towards ending tuberculosis and multidrug-resistant tuberculosis.
Recommendations for a public health approach 2010 revision
Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection

Field Guide for the Management of Drug-Resistant Tuberculosis

A. Piubello The International Union Against Tuberculosis and Lung Disease (2018)
A practical tool to help health workers in the clinical and operational management of multidrug-resistant tuberculosis with special focus on the introduction, implementation and management of the nine-month treatment regimen.
STGs are designed to assist health care professionals in making decisions about appropriate, effective patient care. However, health managers often have trouble setting and meeting the high standards required of modern, developed health care systems. With stakeholders expressing concern over issues ... more
Version: 24 April 2018
Framework for implementation. The END TB Strategy.
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an... more
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this briefing document. It is an overview of the different activities ... more
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379 Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE... more
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti... more
Ce glossaire actualisé sur le paludisme vise à améliorer la communication et la compréhension mutuelle au sein de la communauté scientifique, ainsi qu'avec les organismes de financement, les responsables de la santé publique chargés des programmes de lutte contre le paludisme et les décideur... more
The larval stage of the parasite Taenia solium can encyst in the central nervous system causing neurocysticercosis, which is the main cause of acquired epilepsy in the countries in which the parasite is endemic. Endemic areas are those with the presence (or likely presence) of the full life cycle of... more
“2022 was an eventful year for the WHO Country Office in Ghana,” says Dr Francis Kasolo, WHO Representative to Ghana. In 2022, WHO Ghana collaborated with partners to deliver interventions in support of the Government of Ghana's health sector agenda to ensure healthy lives for all towards ach... more
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202... more
The Global Action Plan on Antimicrobial Resistance (AMR) calls for making AMR a core component of professional education and training. In 2018, the World Health Organization (WHO) published Competency framework for health workers’ education and training on AMR to ensure that academic institutions ... more